Study identifier:D4130C00025
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Phase I, Open-label, Randomized, Single-dose, Two treatment (Fed Versus Fasted) Crossover Study to Assess the Effects of Food on the Pharmacokinetics of TC-5214 (S-Mecamylamine) in Healthy Subjects
Healthy subjects
Phase 1
Yes
TC-5214
All
18
Interventional
18 Years - 55 Years
Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: A - first fed then fasted treatment TC-5214 | Drug: TC-5214 Oral tablets, single 4mg dose |
Experimental: B - first fasted then fed treatment TC-5214 | Drug: TC-5214 Oral tablets, single 4mg dose |